These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10078986

  • 1. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
    Adachi K, Ikeda H, Hasegawa M, Nakamura S, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):143-9. PubMed ID: 10078986
    [Abstract] [Full Text] [Related]

  • 2. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M, Adachi K, Nakamura S, Sato M, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):171-8. PubMed ID: 11448482
    [Abstract] [Full Text] [Related]

  • 3. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S, Lee J, Kiguchi M, Uchida T, Cools AR, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2006 May 24; 538(1-3):94-100. PubMed ID: 16682023
    [Abstract] [Full Text] [Related]

  • 4. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
    Adachi K, Hasegawa M, Fujita S, Lee J, Cools AR, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2003 Jul 18; 473(1):47-54. PubMed ID: 12877937
    [Abstract] [Full Text] [Related]

  • 5. Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vs. D(2)-like receptor regulation.
    Tomiyama K, McNamara FN, Clifford JJ, Kinsella A, Koshikawa N, Waddington JL.
    Eur J Pharmacol; 2001 Apr 20; 418(1-2):47-54. PubMed ID: 11334864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM, Waddington JL.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):175-81. PubMed ID: 8997598
    [Abstract] [Full Text] [Related]

  • 8. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ, Roth BL, Kinsella A, Waddington JL.
    Eur J Pharmacol; 2004 Feb 23; 486(3):273-80. PubMed ID: 14985049
    [Abstract] [Full Text] [Related]

  • 9. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J, Bøgesø KP, Hyttel J, Meier E.
    Pharmacol Toxicol; 1988 Mar 23; 62(3):121-30. PubMed ID: 3259694
    [Abstract] [Full Text] [Related]

  • 10. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell.
    Cools AR, Miwa Y, Koshikawa N.
    Eur J Pharmacol; 1995 Nov 03; 286(1):41-7. PubMed ID: 8566150
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J, Hyttel J, Perregaard J.
    Eur J Pharmacol; 1987 Jan 13; 133(2):137-45. PubMed ID: 2949991
    [Abstract] [Full Text] [Related]

  • 12. Assessment of jaw movements by magnetic sensor in relation to topographies of orofacial behaviour in freely moving rats: Studies with the dopamine D(1)-like receptor agonists SKF 83822 vs SKF 83959.
    Fujita S, Kiguchi M, Kobayashi M, Kinsella A, Koshikawa N, Waddington JL.
    Eur J Pharmacol; 2010 Apr 25; 632(1-3):39-44. PubMed ID: 20122923
    [Abstract] [Full Text] [Related]

  • 13. Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase.
    Clifford JJ, Tighe O, Croke DT, Kinsella A, Sibley DR, Drago J, Waddington JL.
    Neuroscience; 1999 Apr 25; 93(4):1483-9. PubMed ID: 10501473
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK, Senogles SE.
    J Neurochem; 1996 Jan 25; 66(1):222-32. PubMed ID: 8522958
    [Abstract] [Full Text] [Related]

  • 15. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL, Martin LP, Finlay HE, Zahr N, Stellar JR.
    J Pharmacol Exp Ther; 2002 Mar 25; 300(3):850-61. PubMed ID: 11861790
    [Abstract] [Full Text] [Related]

  • 16. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 17. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):237-41. PubMed ID: 7988649
    [Abstract] [Full Text] [Related]

  • 18. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE, Holtzman SG.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):65-75. PubMed ID: 7813580
    [Abstract] [Full Text] [Related]

  • 19. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 20. Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell.
    Uchida T, Adachi K, Fujita S, Lee J, Gionhaku N, Cools AR, Koshikawa N.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):39-47. PubMed ID: 15740723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.